Navigation auf uzh.ch

Suche

UZH News

Archive Medicine and Dentistry 2022

41 articles
Newest Articles

Jahresauswahl

Article list Medicine and Dentistry

  • Human Reproduction Reloaded | H2R

    Should Egg Donation Be Legalized in Switzerland

    A motion has been submitted calling for the legalization of egg donation in Switzerland. Physician Brigitte Leeners and lawyer Andrea Büchler explain why they believe legalization is the way to go.
    More More
  • The LOOP Zurich

    Precise Treatment

    The LOOP Zurich research center combines expertise from UZH, ETH Zurich and the four university hospitals in Zurich with the aim of developing more personalized therapies. Two new projects supported by The LOOP Zurich target urinary tract infections and obesity respectively.
    More More
  • 2022 Koetser Award

    The Causes of Dizziness

    Adolfo Miguel Bronstein has been awarded this year’s Betty and David Koetser Award for Brain Research for his groundbreaking contributions in the field of eye movements, balance and spatial orientation.
    More More
  • Medicine

    heart metabolism

    Researchers from the University of Zurich and ETH Zurich are taking magnetic resonance imaging a step further. With their new method, they can visualize metabolic processes in the body. Their objective is to improve the future diagnosis and treatment of heart disease.
    More More
  • Cardiology

    A Fountain of Youth for Blood Vessels

    Vascular aging is the most common cause of fatal cardiovascular diseases. Can blood vessels be rejuvenated using fat cells? Cardiologist Soheil Saeedi is developing a novel method to do just that.
    More More
  • Biomedicine

    Immune System Reboot in MS Patients

    Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. An UZH study has now examined in detail the way in which the treatment curbs the autoimmune disease and how the immune system regenerates afterwards.
    More More
  • The Art of Learning

    In the Jungle of Neurons

    A big part of learning involves our memory. Neuroscientists are looking closely at what goes on in our brains when we learn, and are slowly unraveling the mysteries of this incredible ability of ours.
    More More
  • Space Research

    A Factory in Outer Space

    It’s possible to produce things in orbit that wouldn’t be possible on Earth, says Oliver Ullrich. We sat down with the biochemist and space physician to learn more about weightless cells, the UZH Space Hub, and humans as an interplanetary species.
    More More
  • The Art of Learning

    Happy Hormones for the Brain

    Good teaching is when learners can make their own connections to knowledge they already have, says Kai Niebert. The education researcher is looking at how teaching is being conducted today and how it can be improved, especially at high school level.
    More More
  • Dental Medicine

    Genetic Defects Lead to Enamel Malformations

    Mutations in a certain molecule result in severe damage in the structure and mineral composition of tooth enamel in mice, according to a study conducted at the UZH Center of Dental Medicine. The researchers combined genetic, molecular and imaging techniques.
    More More
  • Medicine

    Immunotherapy Reduces Lung and Liver Fibrosis in Mice

    Chronic diseases often lead to fibrosis, a condition in which organ tissue suffers from excessive scarring. UZH researchers have now developed an immunotherapy that specifically targets the cause – activated fibroblasts – while leaving normal connective tissue cells unharmed.
    More More
  • New UZH Magazin

    The Art of Learning

    Learning is itself a skill that must be learned. The best ways to do this and the requirements for success are current topics of research at UZH. The new UZH Magazin examines how our ability to learn changes over the course of our lives, how good teaching works, and what goes on in our brains when we learn. The current issue is published jointly by the University of Zurich and UZH Alumni.
    More More
  • Swiss Science Prize Latsis

    “Improved access to medicine and innovative technologies”

    Lawyer and medic Kerstin Noëlle Vokinger has been awarded the Swiss Science Prize Latsis, worth CHF 100,000. The award is made annually to a junior researcher under the age of 40. The professor of public law and digitalization at the University of Zurich is a woman of many talents. She studied law and medicine in parallel and earned doctorates in both disciplines.
    More More
  • Medicine

    High Cholesterol, Overweight and Reduced Physical Stamina Are Long Covid Sequelae in Young Adults

    Healthy young people with just a mild Covid infection can sometimes suffer temporary post-infection consequences such as tiredness, loss of smell and taste or reduced fertility. They usually recover well. In the longer term, metabolic disorders and cardiovascular complications are possible.
    More More
  • Medical genetics

    Genetic Testing Before Pregnancy Detects up to Half of the Risk

    Are would-be parents carrying a genetic risk of serious illnesses that they could potentially pass on to their children? Researchers at the University of Zurich have now shown that a maximal variant of this test detects the risk in 44 percent of couples who are related by blood, and in just 5 percent of other couples.
    More More
  • Medicine

    When the Heart Stops Beating

    Hereditary diseases often play a role when young people succumb to sudden cardiac death. Genetic analysis may prevent further suffering in the affected families, as a study at the Institute of Forensic Medicine has shown.
    More More
  • Epidemiology, Biostatistics and Prevention Institute

    Looking at the Bigger Picture

    Covid infections are on the rise again. Time for UZH epidemiologists Milo Puhan and Viktor von Wyl to take stock and look ahead. With video.
    More More
  • Psychology

    New Sibling Diagnosis for Post-Traumatic Stress Disorder

    The World Health Organization (WHO) recently listed a new sibling diagnosis for post-traumatic stress disorder (PTSD), termed complex post-traumatic stress disorder (CPTSD). An international team with the involvement of the University of Zurich has now summarized the symptoms of the long-awaited new diagnosis and issued guidelines for clinical assessment and treatment.
    More More
  • Sustainable Food

    More Broccoli, Less Steak

    If we want to avoid destroying our planet, we need to transform our eating habits – and this starts in our kitchens. We have to find a balance of healthy and sustainable food, with less meat and more veg.
    More More
  • SNF Grants

    Sebastian Jessberger and Nicola Serra Awarded SNSF Advanced Grants

    The Swiss National Science Foundation is supporting two University of Zurich projects with CHF 2.5 million each. Sebastian Jessberger is investigating the aging process in the brain, while Nicola Serra is on the trail of a sensational development in particle physics.
    More More
  • Medicine

    Nitric Oxide Does Not Improve Babies’ Recovery after Heart Surgery

    Infants undergoing heart surgery are connected to a heart-lung machine and given nitric oxide as an anti-inflammatory. Researchers from the Universities of Zurich and Queensland have now conducted the world’s largest study of its kind, showing that using nitric oxide does not improve children’s recovery after surgery.
    More More
  • UZH Magazin

    eating plants

    Researchers at UZH are exploring sustainable agriculture and the future of food, from transforming our eating habits and growing our own greens to breeding crops with new techniques, distributing seeds more fairly and farming with biodiversity in mind. The latest UZH Magazin explores how we can eat and produce food in a way that benefits both our own health and the health of our planet.
    More More
  • Research Funding

    Boost for One Health and Quantitative Legal Research

    With its new funding instrument, TRANSFORM, UZH is laying the groundwork for innovation across the whole university. The Institute of One Health Research and the Center for Legal Data Science are set to receive seed funding of around CHF 2.7 million in total over the next four years.
    More More
  • Medicine

    A World Premiere: for the First Time, a Human Liver Was Treated in a Machine and then Successfully Transplanted

    The multidisciplinary Zurich research team Liver4Life has succeeded in doing something during a treatment attempt that had never been achieved in the history of medicine until now: it treated an originally damaged human liver in a machine for three days outside of a body and then implanted the recovered organ into a cancer patient. One year later, the patient is doing well.
    More More
  • Geriatric Medicine

    Three Simple Interventions for Cancer Prevention in Older People

    A combination of high-dose vitamin D, omega-3 fatty acids and a simple home strength exercise program (SHEP) can cumulatively reduce the risk of cancer in healthy adults over the age of 70 by 61 percent, the international DO-HEALTH study led by the University of Zurich has shown. It is the first study to test the combined benefit of three affordable public health interventions for the prevention of invasive cancers. The results could influence the future of cancer prevention in older adults.
    More More
  • Covid-19

    Tackling the Consequences of Long Covid

    A research team at the University of Zurich has helped people affected by Long Covid identify the problems they most urgently want scientists to tackle, through a collaborative citizen science approach. The topics identified as most pressing include the development and clinical testing of effective therapies, appropriate healthcare structures, increased awareness as well as better data on children and adolescents affected by the disease.
    More More
  • Space Research

    Universities Space Research Association Elects UZH as a Member University Elects University of Zurich as a Member University

    The University of Zurich (UZH), a renowned university in Switzerland, has joined the ranks of Universities Space Research Association (USRA). Elected by USRA’s current university members, UZH was formally inaugurated into the Association on March 25, 2022, bringing the membership of the Association to a total of 115 universities.
    More More
  • New Center of Competence

    Words that Work

    The new Center of Competence Language & Medicine Zurich connects disciplines and combines basic research with clinical application. We take a look at two of the new center’s projects fostering innovative collaboration between linguistics and medicine at UZH.
    More More
  • Comprehensive Cancer Center Zurich

    Fighting Cancer with Bacteria

    Some bacteria in the gut reduce the effectiveness of cancer treatments, while others increase it. The Comprehensive Cancer Center Zurich is exploring these remarkable abilities in a new flagship project.
    More More
  • Awards

    Three UZH Researchers Awarded ERC Consolidator Grants

    Three researchers at the University of Zurich have been awarded much coveted ERC Consolidator Grants by the EU. Funding in the amount of 6 million euros over five years will not be provided by EU, but instead covered by the federal government as promised.
    More More
  • Medicine

    Patients Share Their Experiences

    What do people with multiple sclerosis, dementia or chronic pain go through? What are their experiences of medical practices or hospitals like? What kind of support do they find helpful? The new dipex.ch platform launched by Zurich researchers makes patient experience reports publicly available.
    More More
  • Immunology

    Multiple Sclerosis: Study with Twins Untangles Environmental and Genetic Influences

    Researchers at the University of Zurich and Munich’s LMU Klinikum hospital have studied the immune system of pairs of monozygotic twins to identify the influence of the environment and of genetics in cases of multiple sclerosis. In the process, they may have discovered precursor cells of the disease-causing T cells.
    More More
  • Neuroscience

    Illuminating Real-Time Brain Dynamics of Neuropeptides with a Fluorescent Biosensor

    Neuropeptides play fundamental roles in modulating cellular and circuit functions within the brain. One such signaling molecule – orexin – regulates arousal and wakefulness, and its failure can lead to constant daytime sleepiness (narcolepsy). University of Zurich researchers have now developed a fluorescent orexin biosensor to observe this molecule "live" in the living mouse brain.
    More More
  • Wyss Zurich Translational Center

    New Foundation for Translational Research and Technology Transfer

    The University of Zurich and ETH Zurich have established the Wyss Zurich Foundation. With this step, the two Zurich universities aim to put the Wyss Zurich Translational Center, a joint accelerator for translational research specializing in regenerative medicine and robotics, on a stable long-term footing.
    More More
  • Covid-19

    Immunological Memory Provides Long-Term Protection against Coronavirus

    Exposure to SARS-CoV-2 by infection or vaccination generates immune cells that provide long-term immunity. These long-lived memory T cells play a key role in preventing severe cases of Covid-19. Researchers at the University of Zurich have now discovered how these memory T cells form.
    More More
  • Spectacular DNA Analysis

    Under Suspicion

    Geneticist Cordula Haas was able to uncover a family secret from the 19th century thanks to unique DNA analyses. She used traces of genetic material from stamps stuck on postcards more than 100 years ago to clear up a paternity mystery.
    More More
  • UZH Spin-Offs in 2021

    Levelling Up

    Every year, innovative UZH researchers launch their own businesses – in 2021, four new spin-offs were founded. Spin-offs play a key role when it comes to transferring scientific findings into industry practice
    More More
  • Successful innovation

    “We have created a stable active ingredient”

    Molecular Partners, a spin-off from the University of Zurich, has developed a drug against Covid-19 and is applying for approval, together with Novartis, in Switzerland and the US. Phase 2 clinical trials have already demonstrated efficacy in Covid patients. Andreas Plückthun of the UZH Department of Biochemistry was involved from the start.
    More More

Jahresauswahl